EFFECTS OF WORTMANNINES, CYCLO-OXYGENASE INHIBITORS AND DEXAMETHASONE ON ENZYME-SECRETION BY MACROPHAGES

被引：0
|
作者：
BAGGIOLINI, M
DEWALD, B
SCHNYDER, J
机构：
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 1980年 / 69卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P269 / P270
页数：2
相关论文
共 50 条
  • [31] POTENTIAL THERAPEUTIC APPLICATIONS OF ASPIRIN AND OTHER CYCLO-OXYGENASE INHIBITORS
    FARAH, AE
    ROSENBERG, F
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 10 : S261 - S278
  • [32] Cyclo-oxygenase inhibitors and Alzheimer's: are we well ADAPTed?
    Pasinetti, GM
    Pompl, PN
    LANCET NEUROLOGY, 2002, 1 (07): : 403 - 404
  • [33] NSAID, type 2 cyclo-oxygenase inhibitors and pancreatic carcinogenesis
    des Guetz, G
    Benamouzig, R
    Breau, JL
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2005, 29 (04): : 411 - 414
  • [34] Cyclo-oxygenase 2 inhibitors, NSAIDs, and the risk of cardiovascular events
    Daniel H Solomon
    Nature Clinical Practice Rheumatology, 2006, 2 : 586 - 587
  • [35] MECHANISMS OF ENZYME-SECRETION BY RABBIT ALVEOLAR MACROPHAGES
    MCCARTHY, K
    HENSON, PM
    FEDERATION PROCEEDINGS, 1979, 38 (03) : 1362 - 1362
  • [36] EFFECT OF DEXAMETHASONE ON CYCLO-OXYGENASE ACTIVITY IN RENO-MEDULLARY CELLS IN CULTURE
    RUSSOMARIE, F
    SEILLAN, C
    DUVAL, D
    AGENTS AND ACTIONS, 1980, 10 (06): : 516 - 519
  • [37] Nonselective cyclo-oxygenase inhibitors and glomerular filtration rate in preterm neonates
    Karel Allegaert
    Christine Vanhole
    Jan de Hoon
    Jean Pierre Guignard
    Dick Tibboel
    Hugo Devlieger
    Bart Van Overmeire
    Pediatric Nephrology, 2005, 20 : 1557 - 1561
  • [38] Allergenic sensitization prevents upregulation of haemopoiesis by cyclo-oxygenase inhibitors in mice
    Lintomen, L
    Elsas, MICG
    Maximiano, ES
    Neto, HAD
    Joseph, D
    Vargaftig, BB
    Elsas, PX
    BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135 (05) : 1315 - 1323
  • [39] Is elevated cardiovascular risk a class effect of cyclo-oxygenase 2 inhibitors?
    Solomon, Scott D.
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2006, 3 (10): : 532 - 533
  • [40] Do cyclo-oxygenase 2 inhibitors increase the risk of cardiovascular events?
    Chan, AT
    Fuchs, CS
    NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (09): : 434 - 435
12345